Rationale and Outcomes for Neoadjuvant Immunotherapy in Urothelial Carcinoma of the Bladder
Year: 2020
Type: article
Study design: Systematic Review
Source: European Urology Oncology
Institutions: Inserm, Université de Versailles Saint-Quentin-en-Yvelines, Université Paris-Saclay, Institut Gustave Roussy, Hôpital Foch, Memorial Sloan Kettering Cancer Center, Harold C. Simmons Comprehensive Cancer Center, The University of Texas Southwestern Medical Center, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, The University of Texas Medical Branch at Galveston, Fondazione IRCCS Istituto Nazionale dei Tumori, The University of Texas MD Anderson Cancer Center, St Bartholomew's Hospital, Queen Mary University of London, Barts Cancer Institute
Language: English
Subfield: Surgery
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W3106449294
